✦ LIBER ✦

Estrogen replacement therapy (ERT) in patients with a history of cervical cancer.

✍ Scribed by G Del Priore; L Franssen; T Olupona; S Harlap

Book ID: 119417480
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 25 KB
Volume: 76
Category: Article
ISSN: 1556-5653
DOI: 10.1016/s0015-0282(01)02172-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Estrogen replacement therapy in women wi

Estrogen replacement therapy in women with a history of breast cancer

✍ M Seifert; A Galid; E Kubista 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 83 KB

Estrogen replacement therapy in patients

Estrogen replacement therapy in patients with early breast cancer

✍ Puthugramam K. Natrajan; R.Don Gambrell Jr 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 58 KB

Estrogen Replacement Therapy Following O

Estrogen Replacement Therapy Following Oophorectomy in Women with a Family History of Ovarian Cancer

✍ Gamal H. Eltabbakh; M.Steven Piver; Ronald E. Hempling; Fernando O. Recio; Chris 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 67 KB

Estrogen replacement therapy in endometr

Estrogen replacement therapy in endometrial cancer patients:: A matched control study

✍ Kimberly A Suriano; Michael McHale; Christine E McLaren; Kuo-Tung Li; Alessandra 📂 Article 📅 2001 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 173 KB

Menopausal estrogen replacement therapy

Menopausal estrogen replacement therapy in women with breast cancer

✍ Kathleen I. Pritchard; Carol A. Sawka 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 244 KB 👁 2 views

Estrogen replacement therapy in women wi

Estrogen replacement therapy in women with a history of proliferative breast disease

✍ William D. Dupont; David L. Page; Fritz F. Parl; W. Dale Plummer Jr.; Peggy A. S 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB 👁 2 views

Dr. Dupont has accepted honoraria for presenting papers at professional meetings from pharmaceutical firms that market hormonal replacement therapy. On three occasions in his career he has been a consultant for Wyeth-Ayerst Pharmaceuticals. The authors thank Marcia G. Freudenthal, Cheryl D. Sharpe,